コーパス検索結果 (right1)
通し番号をクリックするとPubMedの該当ページを表示します
1 fined as feeling informed, defining clear values related to the decision, and active participation in making the decision
2 related to the decision, and active participation in making the decision; and (3) better patient and health system outcom
3 genes, integrates external signals and exerts control over the decision between self-renewal and differentiation at the
4 s a novel regulatory axis that is important for controlling the decision between T cell activation and tolerance via Cbl-
6 munication also makes reported confidence uncorrelated with the decision correctness, thereby nullifying its value in wei
7 ame mechanisms and suggest that stimulus expectation alters the decision criterion but not the sensory signal itself.
8 bjective of the decision process is to identify-at the time the decision is made-the control action that provides the bes
9 Decision confidence is thought to be intimately linked to the decision making process as confidence ratings are tightly
11 evant groups (here, with shared structure) could streamline the decision-making process and may allow for a better integr
12 se regimen of oral cholera vaccine, and show the details of the decision-making process and timeline.
14 h white matter hyperintensities, are of major importance in the decision-making process to focus the diagnosis among the
15 patients with low educational attainment wanted to delegate the decision-making process to the ophthalmologist.
16 es that both physician and patients are actively engaged in the decision-making process, including information exchange;
17 with the preferred role of the attending ophthalmologist in the decision-making processes before treating diabetic retino
18 h concurrent speakers, we find significantly more errors in the decision-making processes triggered by asynchronous audio
19 rmance in motor learning by using parameters estimated from the decision-making task and the separate motor noise measure
21 ess of the initiated treatment and patient participation in the decision of the treatment plan can be implemented.
22 s could be driven by enhanced aversion to uncertainty about the decision outcome (e.g., risk) or aversion to negative out
24 ient's wishes; the family is too distressed and will regret the decision; overruling harms other patients; and regulation
25 ittee judged that these new data did not warrant changes to the decision pathways and algorithms regarding the use of eze
26 opose that DR serotonergic neurons preempt reward delays at the decision point and play a critical role in suppressing im
27 We found that these manipulations, precisely targeted at the decision point, were sufficient to bidirectionally influe
30 The frequency of GS >/=7 tumor for proposed adjustments to the decision rules was 30.0%-60.0% for TZ lesions upgraded fr
31 n visual decision making and may support sensory aspects of the decision, such as interpreting the visual signals so that
32 These findings show that pre and post cues affect the decision through the same mechanisms and suggest that sti
33 g donor, transplant, and recipient characteristics known at the decision time of a transplant, high accuracy in matching
34 0-89 ml/min per 1.73 m(2) as an intermediate range in which the decision to accept or decline is made on the basis of fac
36 Whether CAC score can assist in guiding the decision to initiate statin treatment for primary prevent
37 Continued surveillance is warranted as the decision to introduce protein conjugated vaccine in India
38 ults confirm the explanatory power of self-assessed risk in the decision to migrate or stay and, equally important, confi
39 TF recommends that primary care professionals individualize the decision to offer or refer adults without obesity who do
40 ogether with sensitization status, this forms the basis for the decision to perform a DBPCFC, following a standardized de
41 ency and effectiveness in trial outcome delivery, informing the decision to proceed or stop clinical evaluation of a targ
42 sociated with the decision to take daily tenofovir as PrEP, the decision to return for at least one PrEP follow-up visit,
43 used logistic regression to examine factors associated with the decision to take daily tenofovir as PrEP, the decision to
44 l cortex in humans; vmPFC/mOFC) is involved in constraining the decision to the relevant options.
49 ed patients made more stochastic choices than Controls when the decision was framed by valuable distracting alternatives,
50 ecommendation 6: ACP recommends that clinicians should make the decision whether to treat osteopenic women 65 years of ag
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。